Using ENU based germline forward genetics and CRISPR/Cas9 germline targeting, we demonstrated that a damaging mutation in the Golgi resident protein TVP23B renders mice susceptible to DSS-induced and infectious colitis, which is presumably due to the same mucus defect. Here, TVP23B is linked to infectious colitis.